Abeona Therapeutics Inc. Stock
Price
Target price
?
?
2.510%
0.1
2.510%
€17.10
07:33 / Stuttgart Stock Exchange
WKN: A3DMHM / Symbol: ABEO / Name: Abeona Therapeutics / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Abeona Therapeutics Inc. Stock
There is an upward development for Abeona Therapeutics Inc. compared to yesterday, with an increase of €0.10 (2.510%).
With 10 Buy predictions and only 1 Sell predictions the community sentiment for the stock is positive.
With a target price of 17 € there is potential for a 316.67% increase which would mean more than doubling the current price of 4.08 € for Abeona Therapeutics Inc..
Our community identified positive and negative aspects for Abeona Therapeutics Inc. stock for the coming years. 4 users see the criterium "Worthwhile Investment for the next years" as a plus for the Abeona Therapeutics Inc. stock. On the other hand our users think that "EBIT Margin" could be a problem in the future.
Pros and Cons of Abeona Therapeutics Inc. in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
?
G***** c******* t* c**********
Cons
?
S********** s********
?
M***** P*******
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Abeona Therapeutics Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Abeona Therapeutics Inc. | 2.510% | -8.295% | 1.531% | -28.929% | -24.190% | 6.989% | -86.956% |
| Ardelyx Inc. | -1.300% | -3.964% | 1.395% | -6.825% | -0.463% | 180.604% | -5.108% |
| Krystal Biotech | 0.320% | 0.793% | 7.744% | 6.689% | 25.230% | 150.789% | - |
| Evolus Inc | 0.890% | -4.274% | 0.901% | -54.098% | -46.667% | -18.248% | 84.697% |
Comments
Abeona Therapeutics (NASDAQ:ABEO) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $20.00 price target on the stock.
Show more
Ratings data for ABEO provided by MarketBeat
Abeona Therapeutics Inc. (NASDAQ: ABEO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $20.00 price target on the stock.
Show more
Ratings data for ABEO provided by MarketBeat
Abeona Therapeutics Inc. (NASDAQ: ABEO) had its price target raised by analysts at Oppenheimer Holdings, Inc. from $19.00 to $20.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for ABEO provided by MarketBeat
